Impact of medical professionals on Carbapenem-resistant Pseudomonas aeruginosa: moderating effect of workload based on the panel data in China

BMC Health Services Research
Meng Han, Xinping Zhang

Abstract

Antimicrobial resistance (AMR), especially carbapenem-resistant Pseudomonas aeruginosa (CRPA), causes a serious increase in morbidity, mortality and costs. Medical professionals play an important role in curbing AMR. Previous studies overlooked the impact of workload on the relationship between medical professionals and AMR. This study aimed to explore the relationship between medical professionals and the CRPA rate as well as the moderating effect of medical professionals' workload on this relationship. A provincial-level panel dataset from 2014 to 2017 was constructed. Medical professionals were measured by the numbers of physicians, registered nurses, pharmacists, and clinical microbiologists per 1000 population. Workload was measured by the number of daily physician visits. Fixed effect model and hierarchical regression analysis were performed to explore the moderating effect of workload on medical professionals and the CRPA rate. The numbers of physicians, registered nurses, pharmacists and clinical technicians were significantly negative associated with the CRPA rate (coef. = - 0.889, - 0.775, - 1.176, and - 0.822; P = 0.003, 0.003, 0.011, and 0.007, respectively). Workload had a significant and positive moderating effect...Continue Reading

References

Dec 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy H DellitUNKNOWN Society for Healthcare Epidemiology of America
May 19, 2011·JAMA : the Journal of the American Medical Association·Liselotte N Dyrbye, Tait D Shanafelt
Jun 12, 2013·Lancet·Qi Li, Peng Xie
Feb 25, 2014·Qualitative Health Research·Jonathan PenmBetty Chaar
Apr 2, 2014·JAMA Internal Medicine·Daniel J ElliottPaul Kolm
May 21, 2015·Revista brasileira de anestesiologia·Ilker Onguc AycanEsef Bolat
Sep 13, 2015·Infectious Diseases and Therapy·Mark GilchristHayley Wickens
Nov 26, 2015·Lancet·Ramanan LaxminarayanSally Davies
Dec 20, 2015·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Masayuki MaedaYoshihito Niki
Feb 16, 2016·Current Medical Research and Opinion·António Teixeira RodriguesMaria T Herdeiro
Dec 16, 2016·Medicine·Chien-Huai ChuangYen-Yuan Chen
Jan 13, 2017·Antimicrobial Resistance and Infection Control·Julie StorrUNKNOWN WHO Guidelines Development Group
Apr 4, 2017·Intensive & Critical Care Nursing : the Official Journal of the British Association of Critical Care Nurses·Nohemi Sadule-Rios, Graciela Aguilera
Jul 25, 2017·Intensive Care Medicine·Matteo BassettiAdrian Brink
Aug 5, 2017·American Journal of Infection Control·Elizabeth MonseesLori Popejoy
Aug 6, 2017·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C PulciniM Mendelson
Sep 30, 2017·The Journal of Antimicrobial Chemotherapy·Mohammad AbdallahAbdurahman Alharthy
Sep 21, 2018·Frontiers in Microbiology·Anneke van der ZeeJan Tommassen
Oct 27, 2018·Pharmacy : Journal of Pharmacy, Education and Practice·Inayat Ur RehmanTahir Mehmood Khan
Jan 11, 2019·Antimicrobial Resistance and Infection Control·Di ZhangYalin Dong
Jun 19, 2019·Emerging Infectious Diseases·Maroya Spalding WaltersAlexander Kallen

❮ Previous
Next ❯

Citations

May 17, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Shinya TsuzukiNorio Ohmagari

❮ Previous
Next ❯

Software Mentioned

AMS

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.